Ferguson Wellman Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6M Buy
21,322
+206
+1% +$210K 0.31% 69
2026
Q1
$19.4M Sell
21,116
-387
-2% -$392K 0.27% 78
2025
Q4
$23.1M Buy
21,503
+549
+3% +$525K 0.37% 56
2025
Q3
$16M Buy
20,954
+139
+0.7% +$103K 0.26% 65
2025
Q2
$16.2M Sell
20,815
-283
-1% -$220K 0.29% 62
2025
Q1
$17.4M Buy
21,098
+278
+1% +$231K 0.34% 62
2024
Q4
$16.1M Sell
20,820
-154
-0.7% -$128K 0.31% 65
2024
Q3
$18.6M Sell
20,974
-428
-2% -$385K 0.36% 63
2024
Q2
$19.4M Sell
21,402
-257
-1% -$206K 0.39% 63
2024
Q1
$16.8M Sell
21,659
-39
-0.2% -$27.8K 0.34% 63
2023
Q4
$12.6M Sell
21,698
-643
-3% -$375K 0.28% 71
2023
Q3
$12M Buy
22,341
+71
+0.3% +$36.6K 0.29% 74
2023
Q2
$10.4M Sell
22,270
-129
-0.6% -$54.1K 0.25% 78
2023
Q1
$7.69M Sell
22,399
-396
-2% -$134K 0.19% 81
2022
Q4
$8.34M Buy
22,795
+6,600
+41% +$2.34M 0.22% 78
2022
Q3
$5.24M Sell
16,195
-4,081
-20% -$1.29M 0.2% 73
2022
Q2
$6.57M Buy
20,276
+85
+0.4% +$25.5K 0.24% 75
2022
Q1
$5.78M Sell
20,191
-85
-0.4% -$21.9K 0.18% 86
2021
Q4
$5.6M Sell
20,276
-300
-1% -$76.1K 0.16% 83
2021
Q3
$4.75M Sell
20,576
-149
-0.7% -$36.8K 0.15% 85
2021
Q2
$4.76M Sell
20,725
-314
-1% -$63.1K 0.15% 88
2021
Q1
$3.93M Sell
21,039
-5,848
-22% -$1.14M 0.14% 100
2020
Q4
$4.54M Sell
26,887
-1,316
-5% -$196K 0.11% 137
2020
Q3
$4.17M Sell
28,203
-890
-3% -$138K 0.12% 130
2020
Q2
$4.78M Sell
29,093
-2,200
-7% -$338K 0.15% 119
2020
Q1
$4.34M Sell
31,293
-3,431
-10% -$471K 0.16% 114
2019
Q4
$4.56M Sell
34,724
-2,316
-6% -$268K 0.13% 132
2019
Q3
$4.14M Sell
37,040
-187,235
-83% -$20.8M 0.13% 126
2019
Q2
$24.8M Sell
224,275
-40,285
-15% -$4.74M 0.83% 40
2019
Q1
$34.3M Sell
264,560
-128,479
-33% -$15.6M 1.17% 22
2018
Q4
$45.5M Sell
393,039
-101,698
-21% -$11.4M 1.75% 12
2018
Q3
$53.1M Buy
494,737
+179,671
+57% +$18M 1.74% 13
2018
Q2
$26.9M Buy
315,066
+66,307
+27% +$5.45M 0.94% 30
2018
Q1
$19.2M Buy
248,759
+219,468
+749% +$17.7M 0.68% 42
2017
Q4
$2.47M Sell
29,291
-1,117
-4% -$95K 0.09% 156
2017
Q3
$2.6M Sell
30,408
-269
-0.9% -$22.1K 0.09% 149
2017
Q2
$2.52M Sell
30,677
-565
-2% -$46.1K 0.09% 145
2017
Q1
$2.63M Sell
31,242
-183
-0.6% -$14.7K 0.1% 145
2016
Q4
$2.31M Sell
31,425
-5,514
-15% -$411K 0.09% 149
2016
Q3
$2.96M Sell
36,939
-1,665
-4% -$133K 0.13% 131
2016
Q2
$3.04M Sell
38,604
-2,350
-6% -$177K 0.13% 131
2016
Q1
$2.95M Sell
40,954
-2,357
-5% -$178K 0.13% 129
2015
Q4
$3.65M Sell
43,311
-45,818
-51% -$3.8M 0.15% 135
2015
Q3
$7.46M Buy
89,129
+3,665
+4% +$309K 0.33% 90
2015
Q2
$7.13M Sell
85,464
-55
-0.1% -$4.19K 0.3% 99
2015
Q1
$6.21M Buy
85,519
+3,958
+5% +$282K 0.26% 107
2014
Q4
$5.63M Buy
81,561
+45,707
+127% +$3.09M 0.23% 110
2014
Q3
$2.33M Sell
35,854
-2,296
-6% -$145K 0.1% 158
2014
Q2
$2.37M Buy
38,150
+671
+2% +$40K 0.1% 158
2014
Q1
$2.21M Sell
37,479
-4,820
-11% -$269K 0.1% 156
2013
Q4
$2.16M Sell
42,299
-6,280
-13% -$314K 0.1% 152
2013
Q3
$2.44M Buy
48,579
+3,998
+9% +$209K 0.12% 142
2013
Q2
$2.19M Buy
+44,581
New +$2.43M 0.17% 80

Other funds holding LLY

Ferguson Wellman Capital Management's LLY Position: Q2 2026 in Review

Ferguson Wellman Capital Management increased its Eli Lilly (LLY) stake by 0.98% in Q2 2026, buying an estimated $210K and bringing the position to 21,322 shares worth $25.6M. The position accounts for 0.31% of the portfolio, ranked #69.

Ferguson Wellman Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $53.1M in Q3 2018. 1,615 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ferguson Wellman Capital Management held 21,322 shares of Eli Lilly worth $25.6M as of Q2 2026.
  • Ferguson Wellman Capital Management bought 206 Eli Lilly shares in Q2 2026, an estimated $210K.
  • Eli Lilly made up 0.31% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #69 holding.
  • Ferguson Wellman Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Ferguson Wellman Capital Management's Eli Lilly position peaked at $53.1M in Q3 2018.
  • 1,615 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.